Literature DB >> 23591722

Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach.

Aleksandra M Ignjatović1, Tatjana P Cvetković, Radmila M Pavlović, Vidojko M Đorđević, Zoran G Milošević, Vidosava B Đorđević, Dušica D Pavlović, Ivana R Stojanović, Dragan Bogdanović.   

Abstract

BACKGROUNDS: Cardiovascular disease is reported to be major cause of mortality in dialysis patients. Multimarker approach is new approach in risk stratification. Creating a common predictive value, many different pathophysiological components are covered. The aim of this study was to examine the combined predictive value of markers of endothelial dysfunction (ADMA), inflammation (CRP, SAA) and malnutrition (albumin) in dialysis patients.
METHODS: In this prospective 3-year follow-up study, 153 prevalent patients (105 males and 48 females) on hemodialysis were included. ADMA were measured by HPLC; CRP and SAA were measured using immunonephelometric assays. Albumins were measured by the use of standard methods on the automated analyzer. The patients were stratified into five groups based on the presence of 1, 2, and 3 or more risk markers, respectively, namely high ADMA (≥0.49 μmol/L), high CRP (≥6.0 mg/L), high SAA (≥7.6 mg/L) and low albumin (<30.3 g/L).
RESULTS: The patients with 1, 2, 3 or more risk markers had an adjusted hazard ratio (HR) of 2.419 (0.728-8.034), 6.720 (2.100-21.503), 10.455 (3.193-24.227), respectively, for mortality, compared to those without risk markers. The patients with 1, 2, 3 or more risk markers had an adjusted HR of 1.838 (0.307-11.006), 9.924 (2.052-28.003), 14.823 (0.2.962-34.189), respectively, for cardiovascular mortality than those without risk markers.
CONCLUSIONS: The results of this study demonstrate that the common predictive value of several markers is higher than individual predictive value of examined risk factors. Patients with multiple risk factors had higher mortality. Multimarker approach provides an opportunity for better risk stratification in dialysis patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591722     DOI: 10.1007/s11255-013-0439-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  39 in total

Review 1.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

2.  Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease.

Authors:  Carmine Zoccali; Francesco Antonio Benedetto; Renke Maas; Francesca Mallamaci; Giovanni Tripepi; Lorenzo Salvatore Malatino; Rainer Böger
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

Review 3.  Predictors of cardiovascular death in ESRD.

Authors:  Carmine Zoccali; Giovanni Tripepi; Francesca Mallamaci
Journal:  Semin Nephrol       Date:  2005-11       Impact factor: 5.299

4.  Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

Authors:  Francesca Mallamaci; Giovanni Tripepi; Sebastiano Cutrupi; Lorenzo S Malatino; Carmine Zoccali
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

5.  IL-1β receptor antagonist reduces inflammation in hemodialysis patients.

Authors:  Adriana M Hung; Charles D Ellis; Ayumi Shintani; Cindy Booker; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2011-02-10       Impact factor: 10.121

6.  Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Authors:  A K Cheung; M J Sarnak; G Yan; J T Dwyer; R J Heyka; M V Rocco; B P Teehan; A S Levey
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

Review 7.  Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?

Authors:  Carmine Zoccali; Jan T Kielstein
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-05       Impact factor: 2.894

8.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

9.  Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress.

Authors:  Giuliana Cighetti; Isabella Fermo; Caroline S Aman; Monica Ferraroni; Antonio Secchi; Paolo Fiorina; Rita Paroni
Journal:  Free Radic Biol Med       Date:  2009-05-14       Impact factor: 7.376

10.  Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.

Authors:  Filippo Aucella; Renke Maas; Mimmo Vigilante; Giovanni Tripepi; Edzard Schwedhelm; Maurizio Margaglione; Loreto Gesualdo; Rainer Boeger; Carmine Zoccali
Journal:  Atherosclerosis       Date:  2009-05-21       Impact factor: 5.162

View more
  7 in total

1.  Association between Serum Adipocyte Fatty Acid Binding Protein Level and Endothelial Dysfunction in Chronic Hemodialysis Patients.

Authors:  Hsin-Jou Fan; Chih-Hsien Wang; Bang-Gee Hsu; Jen-Pi Tsai
Journal:  Life (Basel)       Date:  2022-02-20

2.  Gender differences in oxidative and nitrosative stress parameters in kidney transplant patients on tacrolimus-based immunosuppression.

Authors:  Tatjana P Cvetkovic; Nikola Z Stefanovic; Radmila M Velickovic-Radovanovic; Goran J Paunovic; Vidojko M Djordjevic; Dijana R Stojanovic; Ivana R Stojanovic; Dusica D Pavlovic
Journal:  Int Urol Nephrol       Date:  2013-10-08       Impact factor: 2.370

Review 3.  Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.

Authors:  Peter Willeit; Daniel F Freitag; Jari A Laukkanen; Susmita Chowdhury; Reeta Gobin; Manuel Mayr; Emanuele Di Angelantonio; Rajiv Chowdhury
Journal:  J Am Heart Assoc       Date:  2015-05-28       Impact factor: 5.501

Review 4.  Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.

Authors:  Sabrina Schlesinger; Svenja R Sonntag; Wolfgang Lieb; Renke Maas
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

5.  Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol - Differences or Similarities?

Authors:  Tatjana Cvetković; Radmila Veličković-Radovanović; Dijana Stojanović; Nikola Stefanović; Aleksandra Ignjatović; Ivana Stojanović; Nikola Sladojević; Dušica Pavlović
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

Review 6.  Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.

Authors:  Shaoli Zhou; Qianqian Zhu; Xiang Li; Chaojin Chen; Jiping Liu; Yuping Ye; Ying Ruan; Ziqing Hei
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

7.  Circulating Fetuin-A and Risk of All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Zhongwei Zhou; Yuqiao Ji; Huixiang Ju; Hongmei Chen; Mingzhong Sun
Journal:  Front Physiol       Date:  2019-07-30       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.